Literature DB >> 29420716

Racial/Ethnic Disparities in the Lifetime Risk of Chlamydia trachomatis Diagnosis and Adverse Reproductive Health Outcomes Among Women in King County, Washington.

Laura C Chambers1, Christine M Khosropour1, David A Katz2,3, Julia C Dombrowski1,2,3, Lisa E Manhart1,4, Matthew R Golden1,2,3.   

Abstract

Background: Chlamydia trachomatis is the most common reportable infection in the United States and can cause pelvic inflammatory disease (PID) and tubal factor infertility (TFI).
Methods: We created life tables to estimate the "lifetime" risk of chlamydia diagnosis among women aged 15-34 years in King County, Washington, between 1992 and 2014. We estimated the lifetime risk of chlamydia-associated PID and TFI incorporating published estimates of the risk of sequelae.
Results: There were 51464 first chlamydia diagnoses in 1992-2014. For women born between 1980 and 1984, the lifetime risk of chlamydia diagnosis was 19.8% overall and 14.0% for non-Hispanic white, 64.9% for non-Hispanic black, and 32.6% for Hispanic women. The cumulative risk of chlamydia by age 24 increased overall from 13.9% to 17.3% among women born between 1975 and 1994 but declined among non-Hispanic black women, among whom risk by age 24 declined from 57.3% among women born between 1980 and 1984 to 38.6% among women born between 1990 and 1994. The lifetime risk of chlamydia-associated PID among women born between 1980 and 1984 ranged from 0.33% to 1.14%. Among non-Hispanic white, non-Hispanic black, and Hispanic women, the lifetime risk of chlamydia-associated TFI was 0.04%, 0.20%, and 0.10%, respectively. Conclusions: Over 60% of non-Hispanic black women had at least 1 chlamydia diagnosis by age 34 in the birth cohorts most affected, a risk almost 5 times that in non-Hispanic whites. An estimated 1 in 500 non-Hispanic black women develops chlamydia-associated TFI. More effective control measures are needed.

Entities:  

Mesh:

Year:  2018        PMID: 29420716      PMCID: PMC6070060          DOI: 10.1093/cid/ciy099

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.

Authors:  Thomas A Peterman; Lin H Tian; Carol A Metcalf; Catherine L Satterwhite; C Kevin Malotte; Nettie DeAugustine; Sindy M Paul; Helene Cross; Cornelis A Rietmeijer; John M Douglas
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

2.  Modelling the effectiveness of chlamydia screening in England.

Authors:  K M E Turner; E J Adams; D S Lamontagne; L Emmett; K Baster; W J Edmunds
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

3.  Asymptomatic sexually transmitted diseases: the case for screening.

Authors:  Thomas A Farley; Deborah A Cohen; Whitney Elkins
Journal:  Prev Med       Date:  2003-04       Impact factor: 4.018

4.  Coverage is the key for effective screening of Chlamydia trachomatis in Australia.

Authors:  David G Regan; David P Wilson; Jane S Hocking
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

5.  Prevalence of chlamydial and gonococcal infections among young adults in the United States.

Authors:  William C Miller; Carol A Ford; Martina Morris; Mark S Handcock; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

6.  Ethnicity and assisted reproductive technologies.

Authors:  Alicia Armstrong; Torie C Plowden
Journal:  Clin Pract (Lond)       Date:  2012-11-01

7.  Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006.

Authors:  David B Seifer; Rosey Zackula; David A Grainger
Journal:  Fertil Steril       Date:  2009-04-14       Impact factor: 7.329

8.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

9.  Cumulative risk of chlamydial infection among young women in Florida, 2000-2011.

Authors:  Thomas A Peterman; Daniel R Newman; Elizabeth Torrone; Karla Schmitt; Stacy Shiver
Journal:  J Adolesc Health       Date:  2014-04-03       Impact factor: 5.012

10.  Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012).

Authors:  Sarah C Woodhall; Gillian S Wills; Patrick J Horner; Rachel Craig; Jennifer S Mindell; Gary Murphy; Myra O McClure; Kate Soldan; Anthony Nardone; Anne M Johnson
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

View more
  4 in total

1.  Inequities in Chlamydia trachomatis Screening Between Black and White Adolescents in a Large Pediatric Primary Care Network, 2015-2019.

Authors:  Sarah Wood; Jungwon Min; Vicky Tam; Julia Pickel; Danielle Petsis; Kenisha Campbell
Journal:  Am J Public Health       Date:  2022-01       Impact factor: 9.308

2.  An Intervention to Improve Chlamydia and Gonorrhea Testing Among Adolescents in Primary Care.

Authors:  Margaret M Tomcho; Yingbo Lou; Sonja C O'Leary; Deborah J Rinehart; Tara Thomas-Gale; Claudia M Douglas; Florence J Wu; Lara Penny; Steven G Federico; Holly M Frost
Journal:  Pediatrics       Date:  2021-10-21       Impact factor: 7.124

3.  Bacterial Vaginosis and Behavioral Factors Associated With Incident Pelvic Inflammatory Disease in the Longitudinal Study of Vaginal Flora.

Authors:  Rodman Turpin; Susan Tuddenham; Xin He; Mark A Klebanoff; Khalil G Ghanem; Rebecca M Brotman
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

4.  Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis.

Authors:  Minttu M Rönn; Nicolas A Menzies; Thomas L Gift; Harrell W Chesson; Tom A Trikalinos; Meghan Bellerose; Yelena Malyuta; Andrés Berruti; Charlotte A Gaydos; Katherine K Hsu; Joshua A Salomon
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.